Abstract
Background
Type 2 diabetes mellitus (T2DM) is a prevalent chronic disease often accompanied by low-grade inflammation. Recently, the neutrophil-to-lymphocyte ratio (NLR) has garnered researchers’ interest as an emerging inflammation biomarker. This study aimed to comprehensively explore the relationship between NLR and T2DM using the National Health and Nutrition Examination Survey (NHANES) database.
Method
We employed a cross-sectional study design to analyze data from five NHANES cycles from 2007 to 2016, excluding individuals with incomplete data. This study utilized a weighted logistic regression model, subgroup analyses, and restricted cubic spline (RCS) analysis to assess the potential relationship between NLR and T2DM.
Results
A total of 9903 participants were eligible for the analysis, of which 1280 were diagnosed with T2DM. The T2DM group exhibited significantly higher NLR levels than the non-T2DM group. After adjusting for potential confounders, elevated NLR levels were associated with an increased risk of develo** T2DM, indicated by an odds ratio (OR) of 1.14, 95% CI: (1.05,1.24), P = 0.003. The results of the subgroup analyses revealed a significant interaction effect between NLR and T2DM concerning race and hypertension (P for interaction < 0.05). In contrast, no significant interactions were found for age, sex, education level, body mass index (BMI), smoking status, recreational activities, and alcohol drinker (P for interaction > 0.05). RCS analysis showed a significant non-linear relationship between NLR and T2DM, with an inflection point at 2.27 (all P for non-linearity < 0.05).
Conclusion
Our study indicates that an elevated neutrophil-to-lymphocyte ratio is associated with a higher risk of T2DM.
Introduction
Type 2 diabetes mellitus (T2DM), one of the most serious and prevalent chronic diseases, can lead to a variety of complications such as cardiovascular diseases, nephropathy, neuropathy, retinopathy, lower limb amputations, and reduced life expectancy, significantly contributing to increased mortality rates in T2DM patients [1,2,3]. The prevalence of T2DM is rising with the rapid development of the global economy and lifestyle changes. Epidemiological data indicate that, as of 2021, the global prevalence of T2DM among individuals aged 20–79 years was estimated at 10.5% (536.6 million people), with projections suggesting that over 1.31 billion people worldwide could be affected by 2050, with similar rates observed in both genders [4].
The primary clinical criterion for diagnosing T2DM is elevated venous blood glucose levels. T2DM comprises 90% of all cases of diabetes mellitus [5]and is associated with several pathogenic factors, including genetic predispositions, immunological factors, environmental influences, insufficient physical activity, and poor lifestyle choices [6,7,8]. The pathogenesis primarily involves the relative insufficiency of insulin secretion by pancreatic β-cells and the insensitivity of tissues and organs to insulin, which triggers insulin resistance (IR). This leads to a compensatory increase in insulin secretion, ultimately causing pancreatic β-cell damage and failure [9, 10].
The role of inflammation in the development of T2DM and associated metabolic disorders has garnered significant attention [11, 12]. In recent years, the NLR has been increasingly studied as a composite biomarker that better reflects the systemic inflammatory state compared to individual biomarkers, being cost-effective and easy to detect [13,14,15]. NLR has been reported as a reliable inflammatory marker in type 2 DM [16] and other inflammatory conditions including gastrointestinal diseases [17], cardiac conditions [18], thyroiditis [19], thyroid conditions [20], irritable bowel disease [21], and Covid-19 infection [22]. Hence, studying the association between T2DM and NLR is reasonable. However, previous studies have been constrained primarily by their small sample sizes, leaving the relationship between NLR and T2DM ambiguous. Consequently, this study aims to elucidate the potential relationship between NLR and T2DM using a large dataset from the NHANES, seeking to uncover new insights.
Methods
Participant selection and process
The NHANES is a population-based, cross-sectional survey conducted by the Centers for Disease Control and Prevention (CDC) to assess the health and nutritional status of adults and children in the United States. The research team includes professional health investigators, medical technicians, and physicians. The NHANES database, updated biennially, comprises demographic, dietary, examination, laboratory, and questionnaire data. All participant data collection was conducted with informed consent and approved by an ethical review board. We used data from 2007 to 2016 to select participants. We initially screened 50,588 participants, with the specific exclusion criteria as follows: Exclude participants < 20 years old (n = 21,387); Exclude participants lacking education data (n = 39); Exclude participants missing neutrophil and lymphocyte counts (n = 2,508); Exclude participants missing diabetes data (n = 608); Exclude participants lacking other important covariate data (n = 16,143). A total of 9,903 eligible participants were included (Fig. 1).
Detection and definition of NLR
Venous blood was collected in the morning after an overnight fast at the Mobile Examination Centre, and a Beckman Coulter DxH 800 instrument was utilized to perform a complete blood count on the specimen. NLR was determined by dividing the count of neutrophils by that of lymphocytes [23].
Definition of T2DM, hypertension
Diagnosis of T2DM was established based on: (1) self-report of T2DM, (2) fasting blood glucose ≥ 7.0 mmol/L, (3) presence of T2DM symptoms with random blood glucose ≥ 11.1 mmol/L, (4) glycosylated hemoglobin A1c (HbA1c) ≥ 6.5% [24]. Diagnostic criteria for hypertension: NHANES participants were surveyed by healthcare professionals both at home and at the Mobile Examination Center. In the questionnaire, participants were asked, “Have you ever been told you have high blood pressure?” Response options were “Yes” or “No.” Participants answering “Yes” were classified as having hypertension, and those answering “No” were classified as not having hypertension.
Covariates
The covariates comprised demographic, anthropometric, and laboratory measures. The covariates were specified as follows: age groups (20–39, 40–59, and ≥ 60 years), sex (male and female), racial categories (Mexican American, other Hispanic, non-Hispanic white, non-Hispanic black, and other races), education levels (less than high school, high school, or higher), and BMI, classified into three categories: normal, overweight, and obese (< 25 kg/m2, 25–29.9 kg/m2, and ≥ 30 kg/m2). Smoking status was categorized as Never, Former, or Current. Participants were queried regarding whether they had ever smoked 100 cigarettes in their lifetime and if they were currently smoking to distinguish between current and former smokers. Participants were classified as never smokers if they had consumed fewer than 100 cigarettes in their lifetime. Participants were classified as ex-smokers if they were not current smokers but had consumed 100 cigarettes in the past. The activity was defined as any moderate-intensity exercise, fitness, or recreational activity leading to a slight increase in breathing or heart rate-such as brisk walking, bicycling, swimming, or volleyball for at least ten consecutive minutes weekly. Drinkers were defined as individuals who consumed at least 12 alcoholic beverages annually. Additionally, we included hypertension, poverty income ratio (PIR), Total cholesterol (TCHO), triglyceride (TG), Low-density lipoprotein cholesterol (LDL-C), High-density lipoprotein cholesterol (HDL-C), HbA1c. All covariates were sourced from the NHANES database.
Statistical analysis
DecisionLinnc1.0 software was employed for data analysis [25]. DecisionLinnc1.0 is a platform that integrates multiple programming language environments and enables data processing, data analysis, and machine learning through a visual interface. We refer to the “WTMEC2YR” weighting variable and multiply the 2-year MEC weights by one-fifth to derive 10-year weights. Categorical variables are expressed as percentages, Continuous variables are first tested for normality. Data following a normal distribution are represented by Mean ± Standard Deviation, while data not following a normal distribution are often described by the median and interquartile range to depict the central tendency and dispersion. Weighted logistic regression was employed across three distinct models to examine the relationship between NLR and T2DM. Model 1 was not adjusted for covariates. In Model 2, adjustments were made for age, sex, and race. Model 3 included adjustments for sex, age, race, education level, BMI, smoking status, recreational activities, alcohol drinker, hypertension, PIR, TCHO, TG, LDL-C, HDL-C, and HbA1c. Subgroup analyses were also conducted. Furthermore, RCS was utilized to explore potential non-linear relationships between NLR and T2DM risk. P < 0.05 was considered statistically significant.
Results
The characteristics of the participants
A total of 9,903 participants with complete data were included in this analysis (Fig. 1). Of these, 8,623 were non-T2DM, and 1,280 were T2DM. Compared to the normoglycemic group, the diabetic group was older (P < 0.001), better educated (P < 0.001), exhibited a higher obesity rate (P < 0.001), and a greater prevalence of individuals who lacked regular exercise and alcohol drinker (P < 0.001). The differences in PIR, TCHO, TG, LDL-C, HDL-C, and HbA1c between the two groups were statistically significant (P < 0.001). Detailed information can be found in Table 1.
The relationship between NLR and T2DM
As shown in Table 2, a significant correlation was identified between NLR and T2DM. Covariates were not adjusted for in Model 1, while Model 2 was adjusted for age, sex, and race; Model 3 included adjustments for all covariates. In conclusion, analyses revealed that in Model 3, NLR remained positively associated with T2DM (OR:1.14,95%CI:1.05–1.24, P = 0.003). Subsequently, quartile analysis of NLR was conducted, using Q1 as a reference, and the OR for Q4 was significantly higher than that for Q1 (OR: 1.86, 95% CI: 1.58–2.21, P < 0.001). Following complete adjustment for all covariates, Patients in the highest quartile of NLR have a risk of develo** the disease that is more than one time higher than those in the lowest quartile (OR: 1.56, 95% CI: 1.19–2.06, P = 0.002).
Subgroup analyses
To ascertain the robustness of the association between NLR and T2DM across various population subgroups, subgroup analyses were conducted following Model 3. Table 3 demonstrates that the interaction effect between NLR and T2DM was statistically significant concerning race and hypertension (P < 0.05); in contrast, no significant interactions were observed for age, sex, education level, BMI, smoking status, recreational activities, and alcohol drinker (P > 0.05).
Non-linear association between NLR and T2DM
RCS was employed to demonstrate better the relationship between NLR and T2DM (Fig. 2); a strong non-linear correlation was observed between NLR and T2DM,
We conducted a threshold effect analysis and found an inflection point. The inflection points of models 1, 2, and 3 were generally consistent. After adjusting covariates according to Model 3, the inflection point was 2.27. Observations indicate that when NLR is below the inflection point, the risk of T2DM is lower, when NLR exceeds the inflection point, the risk increases rapidly.
Discussion
In this cross-sectional study, we utilized the NHANES database to analyze relevant data from adult participants in the United States. We explored the relationship between NLR and the risk of T2DM, and we concluded: NLR levels in T2DM patients were significantly higher than those in non-T2DM patients. There was a significant positive correlation between NLR and the risk of T2DM, and this relationship persisted even after adjusting for multiple confounding factors. RCS analysis showed a significant nonlinear relationship between NLR and T2DM, with an inflection point at 2.27. The subgroup analyses revealed a significant interaction effect between NLR and T2DM concerning race and hypertension (P for interaction < 0.05). In contrast, no significant interactions were found for age, sex, education level, BMI, smoking status, recreational activities, and alcohol drinker (P for interaction > 0.05).
T2DM represents a prevalent endocrine system disorder characterized by multiple metabolic disturbances that induce a state of chronic hyperglycemia [11, 24]. Evidence suggests that low-grade inflammation plays a crucial role in the pathogenesis of T2DM [26], and HbA1c, a commonly used laboratory marker for diagnosing T2DM, reflects the average blood glucose levels of the human body over three months, facilitating the monitoring of these levels [27]. However, HbA1c does not assess changes in the body’s inflammatory state. The NLR can effectively recognize such changes [28]. In clinical practice, blood counts can be easily tested, offering rapid and cost-effective results. NLR, as a ratio of neutrophils to lymphocytes, provides greater accuracy than a single measurement and effectively reflects the systemic inflammatory response [29]. Neutrophils and T-lymphocytes are pivotal in the development and progression of diabetes. It has been reported that hyperglycemia affects the number and function of circulating neutrophils. However, neutrophils in T1DM and T2DM patients exhibit different characteristics, with increased neutrophil counts observed only in T2DM patients [30]. It has been demonstrated that in patients with T2DM, the expression of activation markers on neutrophil membranes differs from that in healthy controls. This is evidenced by a decreased expression of the adhesion molecule LFA-3, increased levels of activation markers such as CD11B and CD66B, and increased adhesion of neutrophils to endothelial cells, leading to systemic inflammation and endothelial damage [ Our findings indicate a significant positive correlation between neutrophil-to-lymphocyte ratio levels and the risk of T2DM. However, current results cannot determine a causal relationship between the two, further prospective studies are needed to confirm their relationship.Conclusion
Data availability
The NHANES holds the data for all analyses conducted throughout the study period and is available upon request. [https://www.cdc.gov/nchs/nhanes/index.htm].
References
Heald AH, Stedman M, Davies M, Livingston M, Alshames R, Lunt M, Rayman G, Gadsby R. Estimating life years lost to diabetes: outcomes from analysis of National Diabetes Audit and Office of National Statistics data. Cardiovasc Endocrinol Metab. 2020;9(4):183–5.
Harris-Hayes M, Schootman M, Schootman JC, Hastings MK. The role of physical therapists in fighting the type 2 diabetes epidemic. J Orthop Sports Phys Ther. 2020;50(1):5–16.
Cole JB, Florez JC. Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol. 2020;16(7):377–90.
Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, Stein C, Basit A, Chan JCN, Mbanya JC, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.
The L. Diabetes: a defining disease of the 21st century. Lancet. 2023;401(10394):2087.
Sharma U, Chakraborty M, Chutia D, Bhuyan NR. Cellular and molecular mechanisms, genetic predisposition and treatment of diabetes-induced cardiomyopathy. Curr Res Pharmacol Drug Discov. 2022;3:100126.
Arroyo MN, Green JA, Cnop M, Igoillo-Esteve M. tRNA Biology in the pathogenesis of diabetes: role of genetic and environmental factors. Int J Mol Sci 2021, 22(2).
DeFronzo RA, Ferrannini E, Groop L, Henry RR, Herman WH, Holst JJ, Hu FB, Kahn CR, Raz I, Shulman GI, et al. Type 2 diabetes mellitus. Nat Rev Dis Primers. 2015;1:15019.
Mahmoud M, Abdel-Rasheed M. Influence of type 2 diabetes and obesity on adipose mesenchymal stem/stromal cell immunoregulation. Cell Tissue Res. 2023;394(1):33–53.
Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, Ostolaza H, Martin C. Pathophysiology of type 2 diabetes Mellitus. Int J Mol Sci 2020, 21(17).
Tsalamandris S, Antonopoulos AS, Oikonomou E, Papamikroulis GA, Vogiatzi G, Papaioannou S, Deftereos S, Tousoulis D. The role of inflammation in diabetes: current concepts and future perspectives. Eur Cardiol. 2019;14(1):50–9.
Aktas G. Association between the Prognostic Nutritional Index and Chronic Microvascular complications in patients with type 2 diabetes Mellitus. J Clin Med 2023, 12(18).
Misirlioglu NF, Uzun N, Ozen GD, Calik M, Altinbilek E, Sutasir N, Baykara Sayili S, Uzun H. The relationship between Neutrophil-Lymphocyte ratios with Nutritional Status, Risk of Nutritional Indices, Prognostic Nutritional indices and Morbidity in patients with ischemic stroke. Nutrients 2024, 16(8).
Shiny A, Bibin YS, Shanthirani CS, Regin BS, Anjana RM, Balasubramanyam M, Jebarani S, Mohan V. Association of neutrophil-lymphocyte ratio with glucose intolerance: an indicator of systemic inflammation in patients with type 2 diabetes. Diabetes Technol Ther. 2014;16(8):524–30.
Chen Y, Liu J, Li Y, Cong C, Hu Y, Zhang X, Han Q. The Independent Value of Neutrophil to lymphocyte ratio in Gouty Arthritis: a narrative review. J Inflamm Res. 2023;16:4593–601.
Basaran E, Aktas G. The relationship of vitamin D levels with hemogram indices and metabolic parameters in patients with type 2 diabetes mellitus. AIMS Med Sci. 2024;11(1):47–57.
Buse Balci S, Aktas G. A Comprehensive Review of the role of Hemogram Derived inflammatory markers in gastrointestinal conditions. Iran J Colorectal Res. 2022;10(3):75–86.
Sahin S, Sarikaya S, Alcelik A, Erdem A, Tasliyurt T, Akyol L, Altunkas F, Aktas G, Karaman K. Neutrophil to lymphocyte ratio is a useful predictor of atrial fibrillation in patients with diabetes mellitus. Acta Med Mediterranea. 2013;29:847–51.
Aktas G, Sit M, Dikbas O, Erkol H, Altinordu R, Erkus E, Savli H. Elevated neutrophil-to-lymphocyte ratio in the diagnosis of Hashimoto’s thyroiditis. Rev Assoc Med Bras (1992). 2017;63(12):1065–8.
Afsin H, Aktas G. Platelet to lymphocyte and neutrophil to lymphocyte ratios are useful in differentiation of thyroid conditions with normal and increased uptake. Ethiop J HEALTH Dev 2021, 35(3).
Aktas G, Basaran E, Taslamacıoğlu Duman T, Atak B, Kurtkulagi O, Bilgin S, Demirkol M, Kosekli M. Irritable bowel syndrome is associated with novel inflammatory markers derived from hemogram parameters. Family Med Prim Care Rev. 2020;22:107–10.
Aktas G. Hematological predictors of novel coronavirus infection. Rev Assoc Med Bras (1992). 2021;67Suppl 1(Suppl 1):1–2.
Hong J, Lian N, Li M. Association between the neutrophil-to-lymphocyte ratio and psoriasis: a cross-sectional study of the National Health and Nutrition Examination Survey 2011–2014. BMJ Open. 2023;13(12):e077596.
Wu K, Chen L, Kong Y, Zhuo JF, Sun Q, Chang J. The association between serum copper concentration and prevalence of diabetes among US adults with hypertension (NHANES 2011–2016). J Cell Mol Med. 2024;28(8):e18270.
DecisionLinnc Core Team. (2023). DecisionLinnc. 1.0. https://www.statsape.com/.
Munoz Garcia A, Juksar J, Groen N, Zaldumbide A, de Koning E, Carlotti F. Single-cell transcriptomics reveals a role for pancreatic duct cells as potential mediators of inflammation in diabetes mellitus. Front Immunol. 2024;15:1381319.
American Diabetes Association Professional Practice C: 2. Diagnosis and classification of diabetes: standards of Care in Diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S20–42.
Sefil F, Ulutas KT, Dokuyucu R, Sumbul AT, Yengil E, Yagiz AE, Yula E, Ustun I, Gokce C. Investigation of neutrophil lymphocyte ratio and blood glucose regulation in patients with type 2 diabetes mellitus. J Int Med Res. 2014;42(2):581–8.
Kissling M, Fritschi N, Baumann P, Buettcher M, Bonhoeffer J, Naranbhai V, Ritz N. ProPaed, team cs: Monocyte, lymphocyte and Neutrophil Ratios - Easy-to-use biomarkers for the diagnosis of Pediatric Tuberculosis. Pediatr Infect Dis J. 2023;42(6):520–7.
Giovenzana A, Carnovale D, Phillips B, Petrelli A, Giannoukakis N. Neutrophils and their role in the aetiopathogenesis of type 1 and type 2 diabetes. Diabetes Metab Res Rev. 2022;38(1):e3483.
Huang J, **ao Y, Zheng P, Zhou W, Wang Y, Huang G, Xu A, Zhou Z. Distinct neutrophil counts and functions in newly diagnosed type 1 diabetes, latent autoimmune diabetes in adults, and type 2 diabetes. Diabetes Metab Res Rev. 2019;35(1):e3064.
Pezhman L, Tahrani A, Chimen M. Dysregulation of leukocyte trafficking in type 2 diabetes: mechanisms and potential therapeutic avenues. Front Cell Dev Biol. 2021;9:624184.
Munteanu C, Rotariu M, Turnea MA, Anghelescu A, Albadi I, Dogaru G, Silisteanu SC, Ionescu EV, Firan FC, Ionescu AM, et al. Topical reappraisal of molecular pharmacological approaches to endothelial dysfunction in diabetes Mellitus Angiopathy. Curr Issues Mol Biol. 2022;44(8):3378–97.
Watanabe Y, Nagai Y, Honda H, Okamoto N, Yanagibashi T, Ogasawara M, Yamamoto S, Imamura R, Takasaki I, Hara H, et al. Bidirectional crosstalk between neutrophils and adipocytes promotes adipose tissue inflammation. FASEB J. 2019;33(11):11821–35.
Ushakumari CJ, Zhou QL, Wang YH, Na S, Rigor MC, Zhou CY, Kroll MK, Lin BD, Jiang ZY. Neutrophil Elastase Increases Vascular Permeability and Leukocyte Transmigration in Cultured Endothelial Cells and Obese Mice. Cells 2022, 11(15).
**a C, Rao X, Zhong J. Role of T lymphocytes in type 2 diabetes and diabetes-Associated inflammation. J Diabetes Res. 2017;2017:6494795.
Goldmann O, Nwofor OV, Chen Q, Medina E. Mechanisms underlying immunosuppression by regulatory cells. Front Immunol. 2024;15:1328193.
Zhou T, Hu Z, Yang S, Sun L, Yu Z, Wang G. Role of Adaptive and Innate Immunity in Type 2 Diabetes Mellitus. J Diabetes Res 2018, 2018:7457269.
Yu W, Li C, Zhang D, Li Z, **a P, Liu X, Cai X, Yang P, Ling J, Zhang J et al. Advances in T Cells Based on Inflammation in Metabolic Diseases. Cells 2022, 11(22).
Salciccia S, Frisenda M, Bevilacqua G, Viscuso P, Casale P, De Berardinis E, Di Pierro GB, Cattarino S, Giorgino G, Rosati D, et al. Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with non-metastatic and metastatic prostate cancer: a meta-analysis and systematic review. Asian J Urol. 2024;11(2):191–207.
Sayed AA. Assessing the diagnostic values of the neutrophil-to-lymphocyte ratio (NLR) and systematic Immunoinflammatory Index (SII) as biomarkers in Predicting COVID-19 severity: a Multicentre comparative study. Med (Kaunas) 2024, 60(4).
Cai C, Zeng W, Wang H, Ren S. Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and monocyte-to-lymphocyte ratio (MLR) as biomarkers in diagnosis evaluation of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: a retrospective, observational study. Int J Chron Obstruct Pulmon Dis. 2024;19:933–43.
Mohammed AM, Khaleel M, Jalily RMP, Dhanekula QA, Dinesh Eshwar K. Neutrophil-to-lymphocyte ratio as a potential biomarker to managing type 2 diabetes Mellitus and Predicting Disease Progression. Cureus. 2024;16(2):e55227.
Hussain M, Babar MZM, Akhtar L, Hussain MS. Neutrophil lymphocyte ratio (NLR): a well assessment tool of glycemic control in type 2 diabetic patients. Pak J Med Sci. 2017;33(6):1366–70.
Adane T, Melku M, Worku YB, Fasil A, Aynalem M, Kelem A, Getawa S. The Association between Neutrophil-to-Lymphocyte Ratio and Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. J Diabetes Res 2023, 2023:3117396.
Liu S, Zheng H, Zhu X, Mao F, Zhang S, Shi H, Li Y, Lu B. Neutrophil-to-lymphocyte ratio is associated with diabetic peripheral neuropathy in type 2 diabetes patients. Diabetes Res Clin Pract. 2017;130:90–7.
Li X, Wang L, Liu M, Zhou H, Xu H. Association between neutrophil-to-lymphocyte ratio and diabetic kidney disease in type 2 diabetes mellitus patients: a cross-sectional study. Front Endocrinol (Lausanne). 2023;14:1285509.
Li J, Wang X, Jia W, Wang K, Wang W, Diao W, Ou F, Ma J, Yang Y. Association of the systemic immuno-inflammation index, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio with diabetic microvascular complications. Front Endocrinol (Lausanne). 2024;15:1367376.
Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes Mellitus. Endocr Rev. 2016;37(3):278–316.
de Ritter R, de Jong M, Vos RC, van der Kallen CJH, Sep SJS, Woodward M, Stehouwer CDA, Bots ML, Peters SAE. Sex differences in the risk of vascular disease associated with diabetes. Biol Sex Differ. 2020;11(1):1.
Grant B, Sandelson M, Agyemang-Prempeh B, Zalin A. Managing obesity in people with type 2 diabetes. Clin Med (Lond). 2021;21(4):e327–231.
Al-Goblan AS, Al-Alfi MA, Khan MZ. Mechanism linking diabetes mellitus and obesity. Diabetes Metab Syndr Obes. 2014;7:587–91.
Byrne CA, Gomez SL, Kim S, Oddo VM, Koh TJ, Fantuzzi G. Disparities in inflammation between non-hispanic black and white individuals with lung cancer in the Greater Chicago Metropolitan area. Front Immunol. 2022;13:1008674.
Acknowledgements
We express our gratitude to all the staff and participants who took part in the survey.
Funding
The study was not funded.
Author information
Authors and Affiliations
Contributions
HC developed the concept of the paper and authored the initial draft. CW collected the data, LC analyzed the statistical data, RW supervised the project, TZ calibrated the initial draft, and ZH participated in revising the manuscript. To ensure accuracy and consistency, the final manuscript underwent a meticulous review process and received unanimous approval from all authors.
Corresponding author
Ethics declarations
Ethical approval
Ethics approval for the survey protocol was granted by the Ethics Review Board of the National Center for Health Statistics. Written informed consent was secured from each participant before their involvement in the study.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Chen, H., Wu, C., Cao, L. et al. The association between the neutrophil-to-lymphocyte ratio and type 2 diabetes mellitus: a cross-sectional study. BMC Endocr Disord 24, 107 (2024). https://doi.org/10.1186/s12902-024-01637-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12902-024-01637-x